E. Campbell

499 total citations
24 papers, 325 citations indexed

About

E. Campbell is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, E. Campbell has authored 24 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in E. Campbell's work include Renal Diseases and Glomerulopathies (11 papers), Vasculitis and related conditions (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). E. Campbell is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Vasculitis and related conditions (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). E. Campbell collaborates with scholars based in Ireland, United States and United Kingdom. E. Campbell's co-authors include J. J. Walshe, Mark A. Little, Peter Dupont, M. Carmody, J. Donohoe, Andrew Green, Yvonne O’Meara, David P. Hickey, J. Harney and Juliana C.N. Chan and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Alimentary Pharmacology & Therapeutics.

In The Last Decade

E. Campbell

20 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Campbell Ireland 9 164 156 91 75 61 24 325
Alexander Magil Canada 7 145 0.9× 122 0.8× 45 0.5× 67 0.9× 52 0.9× 8 310
Victor Gutierrez‐Millet Spain 10 192 1.2× 82 0.5× 59 0.6× 39 0.5× 28 0.5× 12 328
B Parchoux France 8 216 1.3× 108 0.7× 37 0.4× 101 1.3× 35 0.6× 27 385
Angelo Testa France 9 330 2.0× 116 0.7× 33 0.4× 59 0.8× 79 1.3× 14 470
Arundhati S. Kale United States 10 196 1.2× 72 0.5× 44 0.5× 22 0.3× 35 0.6× 13 322
Rowena Delos Santos United States 8 87 0.5× 67 0.4× 109 1.2× 144 1.9× 49 0.8× 23 322
Vasil Peev United States 7 155 0.9× 36 0.2× 42 0.5× 33 0.4× 41 0.7× 12 277
Zheng Tang China 10 215 1.3× 109 0.7× 18 0.2× 24 0.3× 57 0.9× 25 288
Abdallah Sassine Geara United States 9 82 0.5× 90 0.6× 48 0.5× 16 0.2× 39 0.6× 44 308
Gudrun Norby Norway 8 107 0.7× 48 0.3× 86 0.9× 55 0.7× 65 1.1× 10 293

Countries citing papers authored by E. Campbell

Since Specialization
Citations

This map shows the geographic impact of E. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Campbell more than expected).

Fields of papers citing papers by E. Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Campbell. The network helps show where E. Campbell may publish in the future.

Co-authorship network of co-authors of E. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of E. Campbell. A scholar is included among the top collaborators of E. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Campbell. E. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martin, Claudio M., Marat Slessarev, E. Campbell, et al.. (2023). Annexin A5 in Patients With Severe COVID-19 Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Feasibility Trial. Critical Care Explorations. 5(10). e0986–e0986. 5 indexed citations
3.
Padmanabhan, Hari, et al.. (2016). The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett’s oesophagus cohort. United European Gastroenterology Journal. 4(6). 754–761. 6 indexed citations
4.
Little, Mark A., et al.. (2006). Response to ‘Differences between type I and II membranoproliferative glomerulonephritis’. Kidney International. 70(8). 1527–1527. 1 indexed citations
5.
Little, Mark A., et al.. (2006). Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney International. 69(3). 504–511. 74 indexed citations
6.
Fortun, Paul, George Anagnostopoulos, P Kaye, et al.. (2006). Acetic acid‐enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus. Alimentary Pharmacology & Therapeutics. 23(6). 735–742. 56 indexed citations
7.
Campbell, E., et al.. (2002). Familial membranoproliferative glomerulonephritis type III. American Journal of Kidney Diseases. 40(1). e1.1–e1.6. 15 indexed citations
8.
Stack, Austin G., et al.. (2000). Prevalence and predictors of recurrent IgA nephropathy following renal transplantation. Irish Journal of Medical Science (1971 -). 169(4). 248–252. 5 indexed citations
9.
Vella, John P., et al.. (1997). Light chain deposition disease complicating familial mediterranean fever. American Journal of Kidney Diseases. 29(6). 942–946. 2 indexed citations
10.
Scheinman, Jon I., et al.. (1995). Transplantation for primary hyperoxaluria in the USA. Nephrology Dialysis Transplantation. 10(supp8). 42–46. 27 indexed citations
11.
Campbell, E., et al.. (1995). Renal Failure Associated with Alternative Medical Therapies. Renal Failure. 17(6). 759–764. 8 indexed citations
12.
Harney, J., et al.. (1994). Loin pain-hematuria syndrome: Howeffective is renal autotransplantation in its treatment?. Urology. 44(4). 493–496. 22 indexed citations
13.
Green, Andrew, et al.. (1990). Clinical and histopathologic findings in adults with the nephrotic syndrome. Irish Journal of Medical Science (1971 -). 159(5). 137–140. 13 indexed citations
14.
O’Meara, Yvonne, Andrew Green, M. Carmody, et al.. (1989). Recurrent Glomerulonephritis in Renal Transplants: Fourteen Years' Experience. Nephrology Dialysis Transplantation. 4(8). 730–734. 54 indexed citations
15.
Eustace, Stephen, E. Campbell, Jérôme Fennell, & J. Donohoe. (1988). Eythrocyte sedimentation in nephrotic syndrome. Irish Journal of Medical Science (1971 -). 157(12). 380–382.
16.
Campbell, E., et al.. (1985). An immunohistological study of IgA nephropathy and a report of its incidence in Ireland. Irish Journal of Medical Science (1971 -). 154(12). 461–465. 2 indexed citations
17.
O'Neil, S P, et al.. (1981). Carcinoma of the oesophagus associated with membrano-proliferative glomerulonephritis. Postgraduate Medical Journal. 57(671). 592–596. 6 indexed citations
18.
Campbell, E., et al.. (1979). Systemic lupus erythematosus: Renal involvement and prognosis. Irish Journal of Medical Science (1971 -). 148(1). 255–260.
19.
Carmody, M., et al.. (1976). IgA nephropathy—An immunopathological study. Irish Journal of Medical Science (1971 -). 145(1). 292–303. 6 indexed citations
20.
Campbell, E., et al.. (1976). The Periodic Schiff-Methenamine (PASM) staining of renal biopsies—A light and electron microscopic study. Irish Journal of Medical Science (1971 -). 145(1). 127–134. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Magil Breakdown of academic impact, for papers by Victor Gutierrez‐Millet Breakdown of academic impact, for papers by B Parchoux Breakdown of academic impact, for papers by Angelo Testa Breakdown of academic impact, for papers by Arundhati S. Kale Breakdown of academic impact, for papers by Rowena Delos Santos Breakdown of academic impact, for papers by Vasil Peev Breakdown of academic impact, for papers by Zheng Tang Breakdown of academic impact, for papers by Abdallah Sassine Geara Breakdown of academic impact, for papers by Gudrun Norby
Rankless by CCL
2026